Samuel Takvorian, MD, MSHP is an Assistant Professor in the Division of Hematology and Oncology at the University of Pennsylvania Perelman School of Medicine. His interest in health care policy dates back to an AmeriCorps year, leading health advocacy efforts in a community health center during the implementation of Massachusetts health reform. Later work at Harvard Business School and the Alliance for Health Reform in Washington, D.C. inspired him towards a career in health services and care delivery research. He remains committed to researching questions related to the value of cancer care, encompassing rigorous measurement of both traditional and patient reported outcomes, as well as the costs of care; and to improving the implementation of research findings and innovations into routine practice. He has received multiple mentorship awards for his commitment to medical education, and was awarded the Jane Alavi Award for clinical excellence during his fellowship. He maintains a robust clinical practice in genitourinary oncology. He graduated from Harvard Medical School and completed residency in internal medicine at Brigham and Women’s Hospital in Boston, MA. He served as Chief Fellow while training in Hematology and Oncology at University of Pennsylvania, where he also earned a Master of Science in Health Policy Research.
Senior Fellow
Samuel Takvorian, MD, MSHP
- Assistant Professor, Internal Medicine, Division of Hematology and Oncology, Perelman School of Medicine
Related Content
Increasing the Diversity of Clinical Research Participants
Building Trust is Key to Recruiting Underrepresented Groups
Photo Report: Poster Hall at AcademyHealth ARM 2022
Scientists Return to In-Person Presentation of Their Research
In The Media Medpage Today
Higher Prices, No Difference in Resource Use at NCI Cancer Centers
Work Cited
Expanding Medicaid’s Support for Equitable Access to Clinical Trials
New Coverage Mandate for Routine Costs
Nudging Clinicians Toward Higher-Value Cancer Care
Study shows dramatic improvement in high-value, evidence-based prescribing with behavioral nudges
Medicaid Expansion’s Effects on Patients with Newly Diagnosed, Common Screenable Cancers
Earlier stage diagnosis with no treatment delays
In The Media Journal of the National Cancer Institute
Developing and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action
Author
Supporting Medicare’s Value-Based Transformation
A look at MIPS payment policy
In The Media New England Journal of Medicine
MACRA’s Patient Relationship Codes – Measuring Accountability for Costs
Author